In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Bortezomib,Velcade Drug Master File in Korea (Bortezomib,Velcade KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Bortezomib,Velcade. The MFDS reviews the Bortezomib,Velcade KDMF as part of the drug registration process and uses the information provided in the Bortezomib,Velcade KDMF to evaluate the safety and efficacy of the drug.
After submitting a Bortezomib,Velcade KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Bortezomib,Velcade API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Bortezomib,Velcade suppliers with KDMF on PharmaCompass.